{"title":"静脉注射唑来膦酸钠治疗骨质疏松后急性前葡萄膜炎","authors":"Laurence Rubin, David S. Rosenthal","doi":"10.7326/aimcc.2023.0441","DOIUrl":null,"url":null,"abstract":"Postmenopausal osteoporosis is a common health issue clinicians encounter in practice for which bisphosphonates are commonly prescribed with success. However, these agents may cause intolerable gastrointestinal side effects when administered orally. In such cases, intravenous (IV) bisphosphonates may be prescribed. Post-infusion transient side effects are common, but more uncommon severe adverse effects may develop. We report a case of acute anterior uveitis following the use of IV zoledronate.","PeriodicalId":72222,"journal":{"name":"Annals of internal medicine. Clinical cases","volume":"25 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Acute Anterior Uveitis Following Intravenous Zoledronate for Osteoporosis\",\"authors\":\"Laurence Rubin, David S. Rosenthal\",\"doi\":\"10.7326/aimcc.2023.0441\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Postmenopausal osteoporosis is a common health issue clinicians encounter in practice for which bisphosphonates are commonly prescribed with success. However, these agents may cause intolerable gastrointestinal side effects when administered orally. In such cases, intravenous (IV) bisphosphonates may be prescribed. Post-infusion transient side effects are common, but more uncommon severe adverse effects may develop. We report a case of acute anterior uveitis following the use of IV zoledronate.\",\"PeriodicalId\":72222,\"journal\":{\"name\":\"Annals of internal medicine. Clinical cases\",\"volume\":\"25 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of internal medicine. Clinical cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7326/aimcc.2023.0441\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of internal medicine. Clinical cases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7326/aimcc.2023.0441","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Acute Anterior Uveitis Following Intravenous Zoledronate for Osteoporosis
Postmenopausal osteoporosis is a common health issue clinicians encounter in practice for which bisphosphonates are commonly prescribed with success. However, these agents may cause intolerable gastrointestinal side effects when administered orally. In such cases, intravenous (IV) bisphosphonates may be prescribed. Post-infusion transient side effects are common, but more uncommon severe adverse effects may develop. We report a case of acute anterior uveitis following the use of IV zoledronate.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
